Skip to main content

Table 3 General population utility values

From: Cost-utility of Intravenous Immunoglobulin (IVIG) compared with corticosteroids for the treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Canada

 

Utility Values

Age

Females

Males

35-44

0.91

0.91

45-54

0.85

0.84

55-64

0.81

0.78

65-74

0.78

0.78

75+

0.71

0.75